CIAM
BBNX

Caitong International Asset Management’s Beta Bionics BBNX Stock Holding History

Caitong International Asset Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93K Sell
187
-202
-52% -$2.4K ﹤0.01% 1357
2026
Q1 		$3.9K Sell
389
-1,598
-80% -$23.6K ﹤0.01% 1161
2025
Q4 		$60.5K Buy
1,987
+1,818
+1,076% +$48.5K 0.01% 631
2025
Q3 		$3.36K Sell
169
-376
-69% -$6.61K ﹤0.01% 1308
2025
Q2 		$7.93K Buy
+545
New +$7.71K 0.01% 827

Other funds holding BBNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Caitong International Asset Management's BBNX Position: Q2 2026 in Review

Caitong International Asset Management reduced its Beta Bionics (BBNX) stake by 52% in Q2 2026, selling an estimated $2.4K and leaving 187 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1357.

Caitong International Asset Management first reported a position in BBNX in Q2 2025 and has held it in 5 quarters since. The position peaked at $60.5K in Q4 2025. 43 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Caitong International Asset Management held 187 shares of Beta Bionics worth $2.93K as of Q2 2026.
  • Caitong International Asset Management sold 202 Beta Bionics shares in Q2 2026, an estimated $2.4K.
  • Beta Bionics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1357 holding.
  • Caitong International Asset Management first reported a position in Beta Bionics in Q2 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Beta Bionics position peaked at $60.5K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.